Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 8108754)

Published in Sex Transm Dis on March 24, 1994

Authors

M Hippeläinen1, S Syrjänen, M Hippeläinen, H Koskela, J Pulkkinen, S Saarikoski, K Syrjänen

Author Affiliations

1: Department of Gynecology and Obstetrics, Kuopio University Hospital, Finland.

Articles citing this

Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect (2004) 2.76

Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14

The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis (2007) 2.11

Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect (2002) 2.05

Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer (2012) 1.66

Risk factors for anogenital human papillomavirus infection in men. J Infect Dis (2007) 1.59

Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol (2006) 1.46

Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland. J Clin Microbiol (2005) 1.44

Consistent condom use reduces the genital human papillomavirus burden among high-risk men: the HPV infection in men study. J Infect Dis (2013) 1.43

External genital human papillomavirus prevalence and associated factors among heterosexual men on 5 continents. J Infect Dis (2011) 1.34

Human papillomavirus detection by penile site in young men from Kenya. Sex Transm Dis (2007) 1.28

Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect (2006) 1.21

Human papillomavirus incidence and clearance among HIV-positive and HIV-negative men in sub-Saharan Africa. AIDS (2012) 1.04

Combination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts. Health Qual Life Outcomes (2005) 0.97

HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions. Br J Cancer (2005) 0.94

Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain. BMC Public Health (2016) 0.78

Rome Consensus Conference - statement; human papilloma virus diseases in males. BMC Public Health (2013) 0.77

The role of vaccines in the control of STDs: HPV vaccines. Genitourin Med (1996) 0.77

Oral human papillomavirus infection in men might contribute to HPV serology. Eur J Clin Microbiol Infect Dis (2014) 0.76

Higher prevalence of sexual transmitted diseases and correlates of genital warts among heterosexual males attending sexually transmitted infection clinics (MSCs) in Jiangmen, China: implication for the up-taking of STD related service. PLoS One (2015) 0.75

Articles by these authors

A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg (2000) 2.87

Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer (1992) 1.96

Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol (1995) 1.85

Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer (1994) 1.76

Which factors explain the lower prevalence of atopy amongst farmers' children? Clin Exp Allergy (2003) 1.70

Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia (2001) 1.67

Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg (1983) 1.65

Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med (2001) 1.65

Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes. J Virol Methods (1988) 1.58

Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol (2001) 1.52

Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma. Eur Respir J (2001) 1.50

Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril (1996) 1.47

Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. Prenat Diagn (1996) 1.46

Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer (2009) 1.44

Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Acta Cytol (2000) 1.41

Reproductive performance of women with uterine anomalies. An evaluation of 182 cases. Acta Obstet Gynecol Scand (1982) 1.41

Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer (1994) 1.40

Validity of self-reports of fractures in perimenopausal women. Am J Epidemiol (1999) 1.38

Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33

Weights of placentae from small-for-gestational age infants revisited. Placenta (2001) 1.32

Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol (1983) 1.31

Transgenic mice aberrantly expressing human ornithine decarboxylase gene. J Biol Chem (1991) 1.29

Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study. J Med Screen (2005) 1.27

Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol (1994) 1.27

High and unchanged sperm counts of Finnish men. Int J Androl (1996) 1.27

Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol (1992) 1.26

Bone mineral density and risk factors for osteoporosis--a population-based study of 1600 perimenopausal women. Calcif Tissue Int (1994) 1.24

Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation. Genitourin Med (1993) 1.23

The acetic acid test in evaluation of subclinical genital papillomavirus infection: a comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourin Med (1992) 1.21

Report on consensus conference on cervical cancer screening and management. Int J Cancer (2000) 1.20

Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol (1989) 1.20

Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies. Arch Gynecol (1986) 1.20

Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol (1997) 1.18

Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol (1996) 1.17

Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS (2003) 1.17

Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis (1990) 1.17

The influence of perinatal factors on breast feeding. Acta Paediatr Scand (1983) 1.16

Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer (1993) 1.16

Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ hybridization and polymerase chain reaction. Acta Ophthalmol (Copenh) (1992) 1.14

HIV antibodies in whole saliva detected by ELISA and western blot assays. J Med Virol (1990) 1.14

Responsiveness to mannitol in asthmatic subjects with exercise- and hyperventilation-induced asthma. Am J Respir Crit Care Med (1998) 1.14

Cervical papillomavirus infection progressing to invasive cancer in less than three years. Lancet (1985) 1.13

Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res (1994) 1.13

Hormone receptors as prognostic factors in female breast cancer. Ann Med (1991) 1.12

An improved in situ DNA hybridization protocol for detection of human papillomavirus (HPV) DNA sequences in paraffin-embedded biopsies. J Virol Methods (1986) 1.10

Infectious agents in the etiology of esophageal cancer. Gastroenterology (1992) 1.10

Malignant fibrous histiocytoma of the vulva. Gynecol Oncol (1987) 1.10

Calcaneal ultrasound predicts early postmenopausal fractures as well as axial BMD. A prospective study of 422 women. Osteoporos Int (2004) 1.10

Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol (1993) 1.10

Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09

Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer. Gynecol Oncol (2006) 1.09

Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. Br J Obstet Gynaecol (1985) 1.09

The effect of gynecological risk factors on lumbar and femoral bone mineral density in peri- and postmenopausal women. Maturitas (1995) 1.09

The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin Oncol (1996) 1.08

Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surg (1996) 1.07

Birth weight and sex of children and the correlation to the body burden of PCDDs/PCDFs and PCBs of the mother. Environ Health Perspect (1998) 1.06

Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis (1984) 1.05

Herpes simplex virus type 1 infection has two separate modes of spread in three-dimensional keratinocyte culture. J Gen Virol (1999) 1.05

Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05

Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis (1997) 1.05

Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis (1992) 1.05

Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Br J Cancer (1994) 1.04

Relationship between intra- and postoperative oxygen transport and prolonged intensive care after cardiac surgery: a prospective study. Acta Anaesthesiol Scand (1997) 1.04